Business
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
MISSISSAUGA, Ontario, September 25, 2025--Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic collaboration took effect on September 3, 2025.
About this update from Bayer Ag
[{"type":"image","alt":"From Left to right: Olenka Crewe, VP of Business Development & Scientific Affairs, Mint Pharmaceuticals, Jaiveer Singh, CEO Mint Pharmaceuticals, Viktoria Friedrich, Country President and General Manager – Pharmaceutical Division, Bayer Inc. Jennifer Lloyd, Head of Finance, Pharmaceutical Division, Bayer Inc.","displaySize":"","headline":null,"caption":"From Left to right: Olenka Crewe, VP of Business Development & Scientific Affairs, Mint Pharmaceuticals, Jaiveer Singh, CEO Mint Pharmaceuticals, Viktoria Friedrich, Country President and General Manager – Pharmaceutical Division, Bayer Inc. Jennifer Lloyd, Head of Finance, Pharmaceutical Division, Bayer Inc.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":400,"url":"https://media.zenfs.com/en/business-wire.com/4c102add95e2fa4c2d43d8ec52dbac36"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6Xb0oI_fNnRqFLxFhf7i6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTgwMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4c102add95e2fa4c2d43d8ec52dbac36","width":480,"height":400}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/business-wire.com/c1db42334fa0ca99ffd0828bb96c5a15"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/b3XKaKV1OVRtdOLaJT3Chg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c1db42334fa0ca99ffd0828bb96c5a15","width":400,"height":400}}},{"type":"list","items":[{"val":[{"type":"text","content":"ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to moderate essential hypertension.","length":227,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":227,"olType":false},{"type":"text","content":"MISSISSAUGA, Ontario, September 25, 2025--(BUSINESS WIRE)--Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic collaboration took effect on September 3, 2025.","length":268,"tagName":"p"},{"type":"text","content":""We are excite...